Event Details
August 10, 2022
Description
Start of Cross-Examination of Ms. Meder.
Participants (2)
| Name | Type | Mentions | |
|---|---|---|---|
| Ms. Meder | person | 24 | View Entity |
| MS. MENNINGER | person | 1436 | View Entity |
Source Documents (1)
DOJ-OGR-00018636.jpg
This document is a page from a court transcript (Case 1:20-cr-00330-PAE, likely USA v. Maxwell) filed on August 10, 2022. It details the admission of Government Exhibit 332 under seal to protect a third party's privacy, followed by the jury viewing Exhibits 313 and 332. The prosecution (Ms. Comey) rests, and the defense (Ms. Menninger) begins the cross-examination of witness Ms. Meder regarding photographs copied from CDs to a computer.
Related Events
Events with shared participants
A deposition was conducted, as evidenced by the transcript.
Date unknown • Not specified
Court proceeding regarding witness strategy in United States v. Ghislaine Maxwell (Case 1:20-cr-00330-PAE).
2022-08-10 • Courtroom
A witness, Meder, is questioned about a photograph showing Ghislaine Maxwell and Jeffrey Epstein. The photograph, sourced from a CD (1B63) from the Epstein and Maxwell investigation, is admitted into evidence as Plaintiff's Exhibit 342.
2022-08-10 • Court
Cross-examination of witness Jane by Ms. Menninger in case 1:20-cr-00330-PAE.
2022-08-10
Court hearing regarding redactions and public release of evidence.
2022-08-10 • Courtroom
A legal argument during a court proceeding regarding the admissibility of photographs found in Mr. Epstein's home.
2022-08-10 • Courtroom
A discussion took place regarding the procedural rules for the length and scope of the closing and rebuttal arguments.
2022-08-10 • Courtroom in the Southern District
A charging conference is scheduled for the 18th.
Date unknown • Courtroom
A court hearing where the judge and attorneys discuss resolving an attorney-client privilege issue related to an email.
2022-08-10 • Courtroom
The parties are instructed to confer to try and reach a resolution on the privilege issue.
Date unknown
Discussion 0
No comments yet
Be the first to share your thoughts on this epstein event